Pharmaceutical giant Bristol-Myers Squibb (BMS) sued the federal government late Tuesday to establish a 340B rebate model, joining at least [...] …
Month: November 2024
Drugmaker contact pharmacy restrictions that apply to all covered entities have now outpaced those that only apply to hospitals, according [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Provider groups have strongly denounced Sanofi’s new 340B rebate model for hospitals and health centers as a costly and harmful [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
SPONSORED CONTENT
Join Apexus at an upcoming webinar, Resolving 340B Noncompliance: From Reversals to Refunds, on Wednesday, January 15. This webinar will review different options available for resolving ineligible 340B purchases, including claim reversals, manufacturer repayments, and other options.
Our expert speakers will cover
…
More than a year after a key House panel passed legislation requiring 340B hospitals to report on a number of [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Minnesota providers, namely the state’s largest 340B hospitals, generated hundreds of millions of dollars in collective net revenue from the [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
SPONSORED CONTENT
The Supreme Court recently upended a cornerstone of administrative law, known as “Chevron deference,” in Loper Bright Enterprises v. Raimondo. A major question for 340B stakeholders is how the Loper decision will impact the 340B program.
Although the Loper decision overturned 40 years
…
Three large hospital systems are asking a federal court to immediately block the government from removing them from the 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Breaking News
Wall Street Journal Reports Sanofi Will Become Third Drugmaker to Push for Controversial 340B Rebate
French pharmaceutical giant Sanofi reportedly plans to announce a 340B rebate model for hospitals today, making it the third drugmaker [...] …